These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11503532)

  • 21. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hormone replacement therapy: practical aspects].
    Sonigo C; Dray G; Chabbert-Buffet N
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F3-12. PubMed ID: 23062744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Consultation with regard to benefit-risk assessment and possible side effects of a long-term postmenopausal hormone substitution with estrogens-gestagens. New developments in hormone substitution therapy].
    Lauritzen C
    Zentralbl Gynakol; 2000; 122(2):116-33. PubMed ID: 10721194
    [No Abstract]   [Full Text] [Related]  

  • 24. [Is there a reason for changing the hormone treatment?].
    Luukkainen T
    Duodecim; 1990; 106(23-24):1689-90. PubMed ID: 1364702
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hot confusion about estrogen and breast cancer].
    Ursin G
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2225. PubMed ID: 12426906
    [No Abstract]   [Full Text] [Related]  

  • 26. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
    Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormone replacement therapy against postmenopausal osteoporosis--current recommendations should be revised].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2329-30. PubMed ID: 14508570
    [No Abstract]   [Full Text] [Related]  

  • 32. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 35. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 37. [Positive effects of estrogens on cardiovascular health].
    Fried G
    Lakartidningen; 2002 May; 99(18):2066-7. PubMed ID: 12082786
    [No Abstract]   [Full Text] [Related]  

  • 38. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The combination on conjugated estrogens and medroxyprogesterone in the post-menopause patient and risk of breast cancer: analysis of an uncertain statistic].
    Palma-Aguirre JA; del-Razo OE
    Gac Med Mex; 2002; 138(6):591-2. PubMed ID: 12532627
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estrogen and progesterone replacement in perimenopause and menopause: the urogenital system and sexuality].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Aug; 86(33):1243-4. PubMed ID: 9381008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.